PLX
Price
$1.58
Change
+$0.06 (+3.95%)
Updated
Jun 6 closing price
Capitalization
121M
71 days until earnings call
SRRK
Price
$34.23
Change
-$0.02 (-0.06%)
Updated
Jun 6 closing price
Capitalization
3.25B
59 days until earnings call
Interact to see
Advertisement

PLX vs SRRK

Header iconPLX vs SRRK Comparison
Open Charts PLX vs SRRKBanner chart's image
Protalix BioTherapeutics
Price$1.58
Change+$0.06 (+3.95%)
Volume$468.84K
Capitalization121M
Scholar Rock Holding
Price$34.23
Change-$0.02 (-0.06%)
Volume$1.83M
Capitalization3.25B
PLX vs SRRK Comparison Chart
Loading...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLX vs. SRRK commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLX is a Hold and SRRK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (PLX: $1.59 vs. SRRK: $28.86)
Brand notoriety: PLX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLX: 113% vs. SRRK: 112%
Market capitalization -- PLX: $121M vs. SRRK: $3.25B
PLX [@Biotechnology] is valued at $121M. SRRK’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLX’s FA Score shows that 1 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • PLX’s FA Score: 1 green, 4 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, both PLX and SRRK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLX’s TA Score shows that 5 TA indicator(s) are bullish while SRRK’s TA Score has 3 bullish TA indicator(s).

  • PLX’s TA Score: 5 bullish, 5 bearish.
  • SRRK’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PLX is a better buy in the short-term than SRRK.

Price Growth

PLX (@Biotechnology) experienced а -7.02% price change this week, while SRRK (@Biotechnology) price change was -6.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

PLX is expected to report earnings on Aug 18, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.25B) has a higher market cap than PLX($121M). PLX YTD gains are higher at: -15.426 vs. SRRK (-33.225). PLX has higher annual earnings (EBITDA): 6.52M vs. SRRK (-250.12M). SRRK has more cash in the bank: 437M vs. PLX (34.8M). PLX has less debt than SRRK: PLX (5.53M) vs SRRK (65.1M). PLX has higher revenues than SRRK: PLX (53.4M) vs SRRK (0).
PLXSRRKPLX / SRRK
Capitalization121M3.25B4%
EBITDA6.52M-250.12M-3%
Gain YTD-15.426-33.22546%
P/E Ratio30.40N/A-
Revenue53.4M0-
Total Cash34.8M437M8%
Total Debt5.53M65.1M8%
FUNDAMENTALS RATINGS
PLX vs SRRK: Fundamental Ratings
PLX
SRRK
OUTLOOK RATING
1..100
758
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
7898
PRICE GROWTH RATING
1..100
6544
P/E GROWTH RATING
1..100
7100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRRK's Valuation (63) in the Biotechnology industry is in the same range as PLX (68) in the Servicestothe Health Industry industry. This means that SRRK’s stock grew similarly to PLX’s over the last 12 months.

SRRK's Profit vs Risk Rating (79) in the Biotechnology industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that SRRK’s stock grew similarly to PLX’s over the last 12 months.

PLX's SMR Rating (78) in the Servicestothe Health Industry industry is in the same range as SRRK (98) in the Biotechnology industry. This means that PLX’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Price Growth Rating (44) in the Biotechnology industry is in the same range as PLX (65) in the Servicestothe Health Industry industry. This means that SRRK’s stock grew similarly to PLX’s over the last 12 months.

PLX's P/E Growth Rating (7) in the Servicestothe Health Industry industry is significantly better than the same rating for SRRK (100) in the Biotechnology industry. This means that PLX’s stock grew significantly faster than SRRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLXSRRK
RSI
ODDS (%)
Bullish Trend 12 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
87%
Momentum
ODDS (%)
Bearish Trend 12 days ago
73%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
84%
Bullish Trend about 1 month ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
81%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 12 days ago
88%
Aroon
ODDS (%)
Bullish Trend 12 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+1.92%
IOVA - PLX
50%
Loosely correlated
+1.16%
SRRK - PLX
32%
Poorly correlated
-5.28%
SNDX - PLX
30%
Poorly correlated
+1.91%
DNA - PLX
29%
Poorly correlated
+9.28%
ZNTL - PLX
29%
Poorly correlated
+4.17%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ONCY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ONCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-5.28%
ONCY - SRRK
41%
Loosely correlated
-6.36%
PLRX - SRRK
40%
Loosely correlated
+5.47%
SNDX - SRRK
39%
Loosely correlated
+1.91%
VTGN - SRRK
39%
Loosely correlated
+4.12%
ALT - SRRK
37%
Loosely correlated
-0.36%
More